Cancer surveillance in non-alcoholic fatty liver disease: A potential role for lipidomics

EBioMedicine. 2021 Dec:74:103711. doi: 10.1016/j.ebiom.2021.103711. Epub 2021 Nov 17.
No abstract available

Publication types

  • Letter

MeSH terms

  • Biomarkers
  • Disease Susceptibility
  • Early Detection of Cancer
  • Humans
  • Lipid Metabolism
  • Lipidomics / methods
  • Liver Neoplasms / diagnosis
  • Liver Neoplasms / epidemiology*
  • Liver Neoplasms / etiology*
  • Mass Screening
  • Non-alcoholic Fatty Liver Disease / complications*
  • Non-alcoholic Fatty Liver Disease / epidemiology*
  • Non-alcoholic Fatty Liver Disease / etiology
  • Non-alcoholic Fatty Liver Disease / metabolism
  • Population Surveillance

Substances

  • Biomarkers